Neuropathic Pain – Landscape & Forecast – Disease Landscape & Forecast (G7)

The treatment of neuropathic pain involves the use of drugs from several classes, including antidepressants, antiepileptic drugs, local anesthetics, dual-acting opioid analgesics, and opioid analgesics. Despite the increasing availability of generic options across these drug classes, as well as the continued entrenchment of select therapies as key treatment options for neuropathic pain, unmet need for novel analgesics—particularly those with novel mechanisms of action—remains, driven by the growing prevalence of the neuropathic pain patient population and the sizable percentage of patients who are refractory to current treatment.

Questions answered

• What is the current state of treatment for neuropathic pain? What are interviewed experts’ insights on current treatment options?
• What are the key areas of unmet need in the treatment of neuropathic pain?
• What is the commercial potential of emerging analgesic therapies in the neuropathic pain market should they launch?
• How will the neuropathic pain market evolve over the next decade with the entrance of new treatment options through 2033?

Product description

Disease Landscape & Forecast provides comprehensive market intelligence with world-class epidemiology, keen insight into current treatment paradigms, in-depth pipeline assessments, and drug forecasts supported by detailed primary and secondary research.

Key features

Disease Landscape & Forecast will be updated throughout the year to provide timely insights and analyses as material indication-specific news and events unfold.